| P50 | author | Guillaume Cartron | Q38803376 |
| | Francesco Bertolini | Q56850281 |
| | Stefania Orecchioni | Q56992583 |
| | Martin Villalba | Q57425448 |
| | Nerea Allende-Vega | Q64788606 |
| | Abrar Ul Haq Khan | Q86497987 |
| P2093 | author name string | Charles-Henri Lecellier | |
| | Giovanna Talarico | |
| | Dang-Nghiem Vo | |
| | Moeez G Rathore | |
| | Sana Belkhala | |
| P2860 | cites work | Gene expression profiling indicate role of ER stress in miR-23a~27a~24-2 cluster induced apoptosis in HEK293T cells | Q38335050 |
| | Redox Homeostasis and Mitochondrial Dynamics. | Q38545789 |
| | Oxidative phosphorylation induces de novo expression of the MHC class I in tumor cells through the ERK5 pathway. | Q39664735 |
| | ERK5 knockdown generates mouse leukemia cells with low MHC class I levels that activate NK cells and block tumorigenesis. | Q39876512 |
| | Transcriptional repression of microRNA genes by PML-RARA increases expression of key cancer proteins in acute promyelocytic leukemia | Q39926860 |
| | ERK5 activates NF-kappaB in leukemic T cells and is essential for their growth in vivo. | Q40206582 |
| | Identification of Anti-tumor Cells Carrying Natural Killer (NK) Cell Antigens in Patients With Hematological Cancers | Q41079477 |
| | MEF2 transcriptional activity maintains mitochondrial adaptation in cardiac pressure overload | Q43214524 |
| | SUMOylation regulates the transcriptional activity of JunB in T lymphocytes. | Q46634753 |
| | The high Nrf2 expression in human acute myeloid leukemia is driven by NF-κB and underlies its chemo-resistance. | Q51536210 |
| | Extracellular-signal-regulated kinase 5 modulates the antioxidant response by transcriptionally controlling Sirtuin 1 expression in leukemic cells. | Q54348750 |
| | Big mitogen-activated protein kinase 1 protects cultured rat aortic smooth muscle cells from oxidative damage | Q84151018 |
| | miRNA in the regulation of skeletal muscle adaptation to acute endurance exercise in C57Bl/6J male mice | Q21143777 |
| | Cooperative and individualistic functions of the microRNAs in the miR-23a~27a~24-2 cluster and its implication in human diseases | Q21245705 |
| | Laminar flow activation of ERK5 protein in vascular endothelium leads to atheroprotective effect via NF-E2-related factor 2 (Nrf2) activation | Q24300443 |
| | A microRNA signature of hypoxia | Q24681599 |
| | Oxidative stress responses and NRF2 in human leukaemia | Q26864239 |
| | Chemical metabolic inhibitors for the treatment of blood-borne cancers | Q28822335 |
| | c-Myc suppression of miR-23a/b enhances mitochondrial glutaminase expression and glutamine metabolism | Q29617213 |
| | Nrf2: friend or foe for chemoprevention? | Q33575690 |
| | Evidence that glutamine, not sugar, is the major energy source for cultured HeLa cells | Q34205774 |
| | The NF-κB member p65 controls glutamine metabolism through miR-23a. | Q34277479 |
| | Energy substrate modulates mitochondrial structure and oxidative capacity in cancer cells | Q34297004 |
| | MHC-I modulation due to changes in tumor cell metabolism regulates tumor sensitivity to CTL and NK cells | Q35201839 |
| | MIR-23A microRNA cluster inhibits B-cell development. | Q35214751 |
| | miR-200a regulates Nrf2 activation by targeting Keap1 mRNA in breast cancer cells | Q35562532 |
| | Free radicals and antioxidants in human health: current status and future prospects. | Q36135155 |
| | The presence of wild type p53 in hematological cancers improves the efficacy of combinational therapy targeting metabolism | Q36326369 |
| | Nuclear respiratory factor 1 controls myocyte enhancer factor 2A transcription to provide a mechanism for coordinate expression of respiratory chain subunits | Q36585576 |
| | Differentiation of two types of mobilized peripheral blood stem cells by microRNA and cDNA expression analysis | Q36823321 |
| | Mitochondria: from bioenergetics to the metabolic regulation of carcinogenesis. | Q37410543 |
| | NRF2 and KEAP1 mutations: permanent activation of an adaptive response in cancer | Q37423465 |
| | Distinctions and similarities of cell bioenergetics and the role of mitochondria in hypoxia, cancer, and embryonic development | Q37636772 |
| | Waves of gene regulation suppress and then restore oxidative phosphorylation in cancer cells | Q37749030 |
| | Flow shear stress and atherosclerosis: a matter of site specificity | Q37807049 |
| | From tumor cell metabolism to tumor immune escape | Q38008488 |
| | Rationale for mitochondria-targeting strategies in cancer bioenergetic therapies | Q38024926 |
| | The role of nrf2 and cytoprotection in regulating chemotherapy resistance of human leukemia cells | Q38161353 |
| | Emerging concepts in bioenergetics and cancer research: metabolic flexibility, coupling, symbiosis, switch, oxidative tumors, metabolic remodeling, signaling and bioenergetic therapy | Q38301212 |
| P921 | main subject | leukemia | Q29496 |
| | phosphorylation | Q242736 |
| | reactive oxygen species | Q424361 |
| P304 | page(s) | 43-53 | |
| P577 | publication date | 2015-11-26 | |
| P1433 | published in | EBioMedicine | Q24912341 |
| P1476 | title | Human Leukemic Cells performing Oxidative Phosphorylation (OXPHOS) Generate an Antioxidant Response Independently of Reactive Oxygen species (ROS) Production | |
| P478 | volume | 3 | |